Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(26 sites)

United States

Rady Children's Hospital-San Diego ( Site 2101), San Diego, California

Nicklaus Children's Hospital ( Site 2109), Miami, Florida

Ann & Robert H. Lurie Children's Hospital of Chicago ( Site 2104), Chicago, Illinois

Duke University Medical Center ( Site 2106), Durham, North Carolina

Driscoll Children's Hospital ( Site 2113), Corpus Christi, Texas